about us
the story behind
SeqLL was founded in 2013 to bring a new breed of next generation sequencing technology, True Single Molecule Sequencing (tSMS®), to the research and healthcare markets. By combining top-level scientists and engineers with extensive expertise in NGS applications and systems development, SeqLL® is able to offer collaborative scientific sequencing services and research support including R&D, testing, mapping, and consulting for pharma and biotech. Under our brands SeqLL®, tSMS® and DRS® we are uniquely positioned to address gaps left by standard sequencing technologies in RNA transcriptome analysis, specialty DNA analysis & beyond.
